| |
| |
|
| Insider
Information: |
Mullen James C |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
227,224 |
|
|
Indirect Shares
|
75,000 |
|
|
| Direct
Value |
$30,466,383 |
|
|
|
Indirect Value
|
$17,368,500 |
|
|
| Total
Shares |
302,224 |
|
|
| Total
Value |
$47,834,883 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-2.0
|
| Percentage
Gain/Loss : |
 -18.6%
|
-115.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
CEO & President, Direc... |
2010-06-08 |
95,503 |
2010-06-08 |
75,000 |
Premium* |
|
|
Perkinelmer Inc |
PKI |
Director |
2014-11-14 |
45,551 |
2004-04-27 |
0 |
Premium* |
|
|
Patheon NV |
PTHN |
Chief Executive Office... |
2017-08-29 |
0 |
2017-08-29 |
0 |
Premium* |
|
|
Insulet Corp |
PODD |
Director |
2018-05-16 |
7,783 |
2017-08-09 |
0 |
Premium* |
|
|
Editas Medicine, Inc. |
EDIT |
CEO, Director |
2022-01-03 |
75,898 |
2018-05-18 |
0 |
Premium* |
|
|
Thermo Fisher Scientific |
TMO |
Director |
2023-05-24 |
2,489 |
2019-05-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
180 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
CEO and President |
• • – |
2003-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
44,252 |
44,252 |
|
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2004-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,006 |
1,006 |
|
- |
|
| BIIB |
Biogen Idec Inc |
President and CEO |
• • – |
2004-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
94,252 |
|
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2004-04-27 |
4 |
A |
$19.91 |
$60,009 |
D/D |
3,014 |
4,020 |
|
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2005-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
3,020 |
12,040 |
|
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2007-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
170,000 |
216,458 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2007-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,114 |
18,924 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2008-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
59,300 |
241,208 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2008-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
3,740 |
22,664 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2009-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
49,455 |
185,398 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2009-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,790 |
28,454 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CEO & President |
• • – |
2010-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
48,961 |
144,847 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2011-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,544 |
36,335 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2013-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,263 |
43,178 |
0 |
- |
|
| PKI |
Perkinelmer Inc |
Director |
– • – |
2014-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,373 |
45,551 |
0 |
- |
|
| PTHN |
Patheon NV |
Chief Executive Officer |
• • – |
2016-07-20 |
4 |
A |
$0.00 |
$0 |
D/D |
906,858 |
906,858 |
0 |
- |
|
| PTHN |
Patheon NV |
CEO |
• • – |
2017-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
93,432 |
1,000,290 |
0 |
- |
|
| PODD |
Insulet Corp |
Director |
• • – |
2017-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
3,098 |
3,098 |
0 |
- |
|
| PODD |
Insulet Corp |
Director |
• • – |
2018-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
2,185 |
7,783 |
0 |
- |
|
| TMO |
Thermo Fisher Scientific |
Director |
• • – |
2019-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
718 |
718 |
0 |
- |
|
| TMO |
Thermo Fisher Scientific |
Director |
• • – |
2020-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
572 |
1,290 |
0 |
- |
|
| TMO |
Thermo Fisher Scientific |
Director |
• • – |
2021-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
438 |
1,728 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
CEO |
• • – |
2021-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
36,478 |
71,478 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
CEO |
• • – |
2021-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
36,477 |
94,150 |
0 |
- |
|
| TMO |
Thermo Fisher Scientific |
Director |
• • – |
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
369 |
2,097 |
0 |
- |
|
180 Records found
|
|
Page 1 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
